Melian Agustin 4
4 · Forma Therapeutics Holdings, Inc. · Filed Jul 12, 2022
Insider Transaction Report
Form 4
Melian Agustin
EVP, Research & Development
Transactions
- Award
Stock Option (Right to Buy)
2022-07-11+118,000→ 118,000 totalExercise: $8.20Exp: 2032-07-10→ Common Stock (118,000 underlying) - Award
Common Stock
2022-07-11+79,000→ 79,000 total
Footnotes (2)
- [F1]These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
- [F2]25% of the shares subject to the stock option shall vest on July 11, 2023, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter.